ASX:CHM - CHIMERIC THERAPEUTICS LIMITEDAscending triangle formation is clearly visible. IMO - there is a bit of swing possible still but a good entry point if it breaks 0.345.
$0.345 has been a good resistance level for CHM and can be quite visible.
Fib levels also looking good, breaking the triangle formation, it could go upwards and o
−0.028AUD
−25.92 MAUD
669.36 M
About CHIMERIC THERAPEUTICS LIMITED
Sector
Industry
CEO
Jennifer Chow
Website
Headquarters
Carlton
Founded
2020
ISIN
AU0000121576
FIGI
BBG00YD0SSH0
Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. Its products include NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company was founded by Paul A. Hopper in 2020 and is headquartered in Carlton South, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CHM is 0.034 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CHIMERIC THERAPEUTICS LIMITED stocks are traded under the ticker CHM.
CHIMERIC THERAPEUTICS LIMITED is going to release the next earnings report on Sep 27, 2024. Keep track of upcoming events with our Earnings Calendar.
CHM stock is 0% volatile and has beta coefficient of 0.20. Check out the list of the most volatile stocks — is CHIMERIC THERAPEUTICS LIMITED there?
CHM earnings for the last quarter are −0.03 AUD whereas the estimation was −0.04 AUD which accounts for 31.25% surprise. Estimated earnings for the next quarter are −0.02 AUD. See more details about CHIMERIC THERAPEUTICS LIMITED earnings.
Yes, you can track CHIMERIC THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
CHM stock has fallen by 5.56% compared to the previous week, the month change is a 21.43% rise, over the last year CHIMERIC THERAPEUTICS LIMITED has showed a 51.43% decrease.
CHM net income for the last quarter is 2.44 M AUD, while the quarter before that showed −14.17 M AUD of net income which accounts for 117.25% change. Track more CHIMERIC THERAPEUTICS LIMITED financial stats to get the full picture.
Today CHIMERIC THERAPEUTICS LIMITED has the market capitalization of 28.96 M, it has increased by 6.67% over the last week.
No, CHM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CHM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHIMERIC THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHIMERIC THERAPEUTICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHIMERIC THERAPEUTICS LIMITED stock shows the neutral signal. See more of CHIMERIC THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.